Dr. Reddy's Laboratories Ltd

NSE: DRREDDY · BSE: 500124 · Pharmaceuticals & Biotechnology · 45 announcements

Dr. Reddy's Laboratories Ltd news stories on ALFA NewsRead the news →

Share price: ₹1,198.10
Market cap: ₹1,00,003 Cr
Revenue (annual): ₹33,700 Cr
Net profit (annual): ₹4,196 Cr
P/E (TTM): 31.0×Sector 47.4×
Promoter holding: 26.64%+0.01% QoQ
FII holding: 20.67%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

7 Apr 2026 19:29 IST BSE

Dr. Reddy's Laboratories Merger & Restructuring Worth ₹2.23 Cr

Dr. Reddy's Laboratories Ltd has entered into an agreement to sell its 100% stake in subsidiary Svaas Wellness Limited for ₹2.23 Crore. The buyer, Enspirit Technology Services Private Limited, is not a related party. The divestment is part of a strategic realignment, as the unit contributed only 0.09% to consolidated turnover.

Value: ₹2.23 Cr
Execution: April 7, 2026

Read the filing ↗